Calendar Altamira Therapeutics Nasdaq

Equities

CYTO

BMG0360L2099

Market Closed - Nasdaq 21:30:00 13/05/2024 BST 5-day change 1st Jan Change
1.44 USD -0.69% Intraday chart for Altamira Therapeutics -11.59% -58.33%

Chart calendar Altamira Therapeutics

b8cd9e2e7c76dc45a20c8a97a.OOfpWuzNqcNZ92D18iCFOxPcMz00HewwjuJvYTI2HOg.ba67a4KSxfc2vSOMgGjdAmSWal97WIZotpU2CQdHKrdSq60gu7zbkxjEMQ~29a84a397e6a2a719e65f6a08752d732

Upcoming events on Altamira Therapeutics

14/08/2024 Q2 2024 Earnings Release (Projected)
08/04/2025 Q4 2024 Earnings Release (Projected)
13/08/2025 Q2 2025 Earnings Release (Projected)
14/04/2026 Q4 2025 Earnings Release (Projected)

Past events on Altamira Therapeutics

10/04/2024 13:30 Q4 2023 Earnings Call
10/04/2024 13:00 Q4 2023 Earnings Release
22/01/2024 MRNA Based Therapeutics Summit
11/12/2023 13:30 Business Update Call
12/09/2023 13:00 Q2 2023 Earnings Call
12/09/2023 12:30 Q2 2023 Earnings Release
11/09/2023 12:00 H.C. Wainwright Global Investment Conference
20/03/2023 RNAi Based Therapeutics Summit
25/02/2023 15:45 American Academy of Allergy, Asthma & Immunology Meeting
17/02/2023 12:30 Extraordinary Shareholders Meeting
07/02/2023 RNA Therapeutics Conference
23/01/2023 mRNA-Based Therapeutics Summit Europe Conference
30/11/2022 13:47 Interim 2022 Earnings Release
15/11/2022 TIDES Europe Event
17/10/2022 RNA Leaders USA Congress
25/09/2022 RAS-Targeted Drug Development Summit
14/09/2022 15:30 Business Update Call
24/05/2022 12:00 H.C. Wainwright Global Life Sciences Investment Conference
12/04/2022 13:00 FY 2021 Earnings Call
12/04/2022 12:30 FY 2021 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2023 2024
Net sales
Million CHF
Released
Forecast
Spread
0,00
0,00
-
0,00



0,00

EBITDA
Million CHF
Released
Forecast
Spread
-7,23
-11,0
33.99%
0,00



0,00

EBIT
Million CHF
Released
Forecast
Spread
-7,26
-10,6
31.76%
0,00



-7,85

Earnings before Tax (EBT)
Million CHF
Released
Forecast
Spread
-6,83
-10,7
36.24%
0,00



0,00

Net income
Million CHF
Released
Forecast
Spread
-6,63
-9,31
28.74%
-3,87



0,00

EPS
CHF
Released
Forecast
Spread
-912
-1 338
31.84%
-7,88



0,00

Announcement Date16/04/2010/04/24-

Quarterly results

Fiscal PeriodDecember 2019 S2 2024 S1 2024 S2 2025 S1 2025 S2
Net sales
Million CHF
Released
Forecast
Spread




0,00


0,00


0,00


0,00

EBIT
Million CHF
Released
Forecast
Spread
-3,15
-5,23
39.68%












Net income
Million CHF
Released
Forecast
Spread
-3,03
-4,83
37.25%












EPS
CHF
Released
Forecast
Spread
-248
-588
57.82%












Announcement Date16/04/20----

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CYTO Stock
  4. CYTO Stock
  5. Calendar Altamira Therapeutics